Dicerna secures right to sublicense Dicer Substrate Technology platform
Dicerna’s pipeline of RNAi-targeted drugs and delivery systems is focused primarily in the therapeutic areas of oncology and metabolic diseases. In addition to these internal focus areas, Dicerna
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.